Andrea Schreiber is an associate in the Corporate Group. She focuses her practice on public and private merger and acquisition transactions, as well as other corporate transactions and securities law matters. In addition, Ms. Schreiber counsels clients on corporate governance matters and assists companies in preparing filings that are required under the Securities and Exchange Commission's periodic reporting system. Ms. Schreiber also advises clients on choice of entity decisions, entity formation, joint venture projects and limited liability company agreements.
Some of Ms. Schreiber's recent corporate transactions include representation of:
- Ipreo Holdings LLC in its sale to KKR
- Boomi, Inc. in its sale to Dell
- Intelligroup, Inc. in its two step tender offer/merger with NTT Data Corporation
- NeoStem, Inc. in its acquisition of China Biopharmaceuticals Holdings, Inc. via merger
- GF Capital Private Equity Fund, L.P. in its acquisition of the assets of Airborne Health, Inc.
- Vital Signs, Inc. in its $870 million cash merger with GE Healthcare
- LifeCell Corporation in its $1.7 billion two step tender offer/merger with Kinetic Concepts, Inc.
|